News from telik, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 11, 2014, 09:00 ET

Telik Announces New Board of Director Members to Oversee Reinvigorated Cancer Therapy Pipeline Resulting from the Recent Merger with MabVax Therapeutics, Inc.

 Telik, Inc. (OTCQB: TELK), a clinical stage oncology drug development company, which recently merged with MabVax Therapeutics, Inc. on July 8,...

Aug 04, 2014, 09:00 ET

Telik Announces Plans for Special Meeting of Stockholders and Transition to MabVax Therapeutics Holdings, Inc.

 As previously announced, MabVax Therapeutics, Inc., a privately held cancer immunotherapy company, and Telik, Inc. (OTCQB: TELK), aclinical...

Jul 09, 2014, 09:30 ET

MabVax Therapeutics And Telik Announce Closing of Merger

MabVax Therapeutics, Inc., a privately held cancer immunotherapy company, and Telik, Inc. (Nasdaq: TELK), a publicly-traded clinical stage oncology...

May 15, 2014, 16:05 ET

Telik Announces First Quarter 2014 Financial Results

Telik, Inc. (Nasdaq: TELK) today reported financial results for the first quarter ended March 31, 2014.  The net loss for the quarter ended...

May 12, 2014, 16:30 ET

Telik and MabVax Therapeutics Announce Definitive Merger Agreement

 Telik, Inc. (Nasdaq: TELK), a clinical stage oncology drug development company, and MabVax Therapeutics, Inc., a privately held cancer...

Mar 10, 2014, 16:15 ET

Telik Announces Fourth Quarter And 2013 Year End Financial Results

 Telik, Inc. (Nasdaq: TELK) reported a net loss of $0.8 million, or $0.17 per share, for the three months ended December 31, 2013, compared...

Nov 12, 2013, 16:20 ET

Telik Announces Third Quarter 2013 Financial Results

 Telik, Inc. (Nasdaq: TELK) today reported a net loss of $1.1 million, or $0.25 per share, for the third quarter ended September 30, 2013,...

Aug 09, 2013, 16:15 ET

Telik Announces Second Quarter 2013 Financial Results

 Telik, Inc. (Nasdaq: TELK) today reported a net loss of $1.4 million, or $0.30 per share, for the second quarter ended June 30, 2013, compared...

May 10, 2013, 16:30 ET

Telik Announces First Quarter 2013 Financial Results

 Telik, Inc. (Nasdaq: TELK) today reported financial results for the first quarter ended March 31, 2013.  The net loss for the quarter...

Mar 15, 2013, 16:30 ET

Telik Announces Fourth Quarter And 2012 Year End Financial Results And 2013 Financial Guidance

 Telik, Inc. (Nasdaq: TELK) reported a net loss of $1.8 million, or $0.66 per share, for the three months ended December 31, 2012, compared...

Jan 22, 2013, 17:30 ET

Telik Announces Preliminary Agreement On Design Of Phase 3 Registration Trial Of Telintra® In Low To Intermediate-1 Risk Myelodysplastic Syndrome

 Telik, Inc. (Nasdaq: TELK) announced the completion of an End of Phase 2 meeting with the US Food and Drug Administration (FDA). ...

Jan 11, 2013, 19:23 ET

Telik Announces Orphan Designation Of Telintra® For Treatment Of Myelodysplastic Syndrome

 Telik, Inc. (Nasdaq: TELK) was notified today that its product candidate, ezatiostat HCL (Telintra), has been granted orphan drug designation...

Dec 12, 2012, 16:20 ET

Telik Announces Telintra® Clinical Publication at the 54th Annual Meeting of the American Society of Hematology

Telik, Inc. (Nasdaq: TELK) announced today the publication of a clinical trial abstract in the proceedings of the 54th Annual Meeting of the...

Nov 09, 2012, 16:15 ET

Telik Announces Third Quarter 2012 Financial Results

 Telik, Inc. (Nasdaq: TELK) today reported a net loss of $1.9 million, or $0.78 per share, for the third quarter ended September 30, 2012,...

Aug 10, 2012, 16:05 ET

Telik Announces Second Quarter 2012 Financial Results

Telik, Inc. (Nasdaq: TELK) today reported a net loss of $2.1 million, or $1.11 per share, for the second quarter ended June 30, 2012, compared with...

May 09, 2012, 16:15 ET

Telik Announces First Quarter 2012 Financial Results

 Telik, Inc. (Nasdaq: TELK) today reported financial results for the first quarter ended March 31, 2012.  The net loss for the quarter...

Apr 17, 2012, 16:59 ET

Telik Regains Compliance With Minimum Bid Price Requirement

 Telik, Inc. (Nasdaq: TELK) today announced that it has received from The Nasdaq Stock Market notification that Telik has regained compliance...

Mar 30, 2012, 13:00 ET

Telik Announces Reverse Split of Common Stock

 Telik, Inc. (NASDAQ: TELK) today announced a 1-for-30 reverse split of its common stock.  Telik's common stock will begin trading on a...

Feb 23, 2012, 16:05 ET

Telik Announces Fourth Quarter and 2011 Year End Financial Results and 2012 Financial Guidance

Telik, Inc. (Nasdaq: TELK) reported a net loss of $2.5 million, or $0.05 per share, for the three months ended December 31, 2011, compared with a...